Capturing the Heart of K-beauty

Beyond Care to Cure: Opening the Future of K-Beauty

SKINMED Co., Ltd. (CEO Jaewook Heo) is a derma-cosmetic company that is redefining K-beauty based on dermatological science and medicine.

Headquartered in Yuseong District, Daejeon, SKINMED has focused on research and development to improve not only skin aesthetics but also intractable skin conditions such as atopic dermatitis, psoriasis, wrinkles, and hair loss under the philosophy of “Beyond Care to Cure.”

SKINMED has established an advanced R&D system with participation from dermatology professors and researchers from major university hospitals nationwide. The company operates two in-house clinical trial centers, adhering to the principle of scientifically verifying product efficacy before commercialization. Through KGMP and ISO 22716 certified production facilities, SKINMED stably supplies medical device (MD) products, functional cosmetics, and hospital-exclusive skincare products.

Notably, their independently developed 'Medipep-6PN' peptide, high-concentration long-chain ceramides, and nano DDS (Drug Delivery System) technology are crucial in addressing various skin concerns, including wrinkles, whitening, and skin barrier strengthening. Among these, the 'rapid-acting wrinkle treatment peptide' is gaining attention as an innovative technology that offers six times greater safety than Botox and shows effects within one hour of application.

Recently, SKINMED launched Korea’s first Class II medical device sunscreen with integrated UV protection. The company’s products, including this innovation, are now available through more than 300 domestic distribution channels, primarily in hospitals, clinics, pharmacies, and aesthetic centers.
In addition to its strong domestic presence, SKINMED is rapidly expanding its global footprint, exporting to Japan, China, Southeast Asia, the United States, and Europe. The company is emerging as a leading global brand in the premium segment of K-beauty.

As K-beauty continues to evolve into a next-generation, science-driven market, SKINMED is poised for dynamic growth both at home and abroad—powered by its medical credibility and clinically validated technological expertise.

Source : SKINMED

Kimbelle Dermatologic Hospital, Korea's Only Secondary Dermatology Hospital

Skin occupies the most significant body area and is a vital organ that protects us from external stimuli. Skin health extends beyond mere aesthetics, directly affecting overall health and quality of daily life. While dermatology clinics are often associated primarily with cosmetic procedures, insurance-covered treatment for various skin conditions constitutes the core role of dermatology. Burns, scars, vitiligo, psoriasis, atopic dermatitis, and contact dermatitis require professional diagnosis and treatment, as self-treatment or general management alone rarely achieves fundamental improvement.

Kimbelle Dermatologic Hospital (Director Dongha Kim) is Korea's first secondary dermatology hospital, equipped with a hospital-grade medical system capable of providing accurate diagnosis, treatment, surgery, and hospitalization for skin diseases. Four dermatology specialists are permanently stationed at the hospital, offering customized treatment and advanced medical services through a specialized treatment system for different conditions.

Among these conditions, vitiligo is a skin disease experienced by many people but difficult to discuss openly. It is an autoimmune disorder where melanin cells are destroyed, causing partial loss of skin pigmentation, and is the most common acquired depigmentation disorder. The visible symptoms often significantly impact patients' self-esteem and daily life. As it's not merely a cosmetic issue but a condition accompanied by profound emotional difficulties, accurate and systematic treatment is essential. Kimbelle Dermatologic Hospital leads in vitiligo treatment through excimer laser therapy.

Excimer laser treatment is a therapeutic approach directly irradiates affected areas with a 308nm wavelength laser to induce skin pigment regeneration. It does not damage surrounding healthy skin and has minimal side effects, resulting in high patient satisfaction.

Kimbelle Dermatologic Hospital approaches vitiligo as a skin problem and aims for an integrated treatment approach that considers patients' quality of life and psychological stability. They provide treatment solutions optimized for each patient based on extensive clinical experience and a hospital-grade system.

Source : KIMBELLE Dermatologic Hospital

Other Article